Autres langues Compugen Ltd. TEL AVIV STOCK EXCHANGE

Actions

CGEN

IL0010852080

Recherche biotechnologique et médicale

Temps Différé TEL AVIV STOCK EXCHANGE 13:30:29 06/10/2026			Varia. 5j.	Varia. 1 janv.
711,00 ^ILa	+1,98%		-2,43%	+51,92%

05/10	Transcript : Compugen Ltd. - Special Call
03/08	Compugen Ltd. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

03/08	Compugen Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
03/08	Compugen : Corporate Presentation
03/08	Compugen : CGEN Corporate Deck
03/08	Compugen: Q2 Earnings Snapshot
03/08	Compugen Reports Second Quarter 2026 Results
21/07	Compugen to Participate in BTIG Biotechnology Conference 2026
18/06	Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
11/06	Compugen Presents Trial-In-Progress Poster On MAIA-Ovarian Phase 1 Study Of COM701 At ESMO Gynaecological Cancers Congress 2026
11/06	Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
08/06	Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
19/05	Compugen : Corporate Presentation
18/05	Compugen Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
18/05	Compugen Files $400 Million Mixed Shelf
18/05	Compugen: Q1 Earnings Snapshot
18/05	Compugen : First Quarter 2026 Press Release
18/05	Compugen Reports First Quarter 2026 Results
12/05	Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
02/03	Compugen Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
02/03	Compugen: Q4 Earnings Snapshot
02/03	Compugen : Corporate Presentation
02/03	Compugen : Fourth Quarter 2025 Press Release
02/03	Compugen Reports Fourth Quarter and Full Year 2025 Results
17/02	Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026
12/02	Compugen announces the appointment of Michele Holcomb, Ph.D., to its board of directors
12/02	Compugen Ltd. Appoints Michele Holcomb to Its Board of Directors, Effective February 11, 2026